Can molotinib be purchased in China and how much does it cost?

Momelotinib (Momelotinib), also known as Ojjaara, is an important therapeutic drug, especially for patients with myelofibrosis. It has important therapeutic value. However, whether molotinib is available in China and its price are the focus of concern for many patients and their families. Here are detailed answers to these two questions:

1. Is molotinib available in China?

Currently, molotinib has not received official marketing approval in China, so patients may not be able to purchase this drug directly in traditional pharmacies or hospital pharmacies. However, for some patients with special needs, they may obtain this drug through other means, such as by consulting regular overseas medical institutions or participating in clinical trials. However, the feasibility and legality of these pathways require careful screening and evaluation by patients and families.

2. What is the price of molotinib?

Currently overseas, a box of molotinib’s original drug sells for approximately more than 50,000 yuan, but this is not a fixed price. In fact, the price of drugs will be affected by many factors, including specifications, scarcity, transportation costs, market demand, etc. The actual selling price in pharmacies shall prevail.

It should be noted that since molotinib is a prescription drug, its use needs to be under the guidance of a doctor. Please check regularly and pay attention to your discomfort symptoms during the medication. If you have any questions, communicate with your attending doctor in a timely manner.

In general, molotinib has not yet been officially launched in China, and there are certain complexities and uncertainties in its purchase and price. The best advice for patients who require treatment with this drug is to seek professional medical consultation and pay close attention to relevant medical policies and market dynamics.